Wedbush downgraded shares of Ikena Oncology (NASDAQ:IKNA – Free Report) from an outperform rating to a neutral rating in a research report sent to investors on Wednesday morning, MarketBeat reports. The brokerage currently has $2.00 target price on the stock, down from their previous target price of $8.00. Wedbush also issued estimates for Ikena Oncology’s […]
Decheng Capital LLC Acquires New Shares in Pyxis Oncology, Inc. (NASDAQ:PYXS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […]
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.50 Consensus Target Price from Brokerages dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Cardiff Oncology's (CRDF) "Buy" Rating Reiterated at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.